More Post from the Author
- Johnny Lieberman of Harbor IT named Entrepreneur Of The Year 2026 New York finalist by EY US
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
Booking Holdings Inc. to Present at the Morgan Stanley Technology, Media & Telecom Conference
NORWALK, Conn., Feb. 24, 2025 /PRNewswire/ -- Booking Holdings (NASDAQ: BKNG) today announced that Chief Financial Officer Ewout Steenbergen will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference, held in San Francisco, on March 5, beginning at 3:20 pm PT / 6:20pm ET. A live audio cast of the presentation will be available to the public at https://ir.bookingholdings.com/events, and a replay will be available approximately 24 hours later.
Source: Booking Holdings
#BKNG_Corporate
About Booking Holdings
Booking Holdings (NASDAQ: BKNG) is the world's leading provider of online travel and related services, provided to consumers and local partners in more than 220 countries and territories through five primary consumer-facing brands: Booking.com, Priceline, Agoda, KAYAK and OpenTable. The mission of Booking Holdings is to make it easier for everyone to experience the world. For more information, visit BookingHoldings.com and follow us on X @BookingHoldings.
SOURCE Booking Holdings

More Post from the Author
- Johnny Lieberman of Harbor IT named Entrepreneur Of The Year 2026 New York finalist by EY US
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
